Clinical Trial news from FierceHealthcare
Press Releases
PHT Corporation Achieves Record Bookings, Revenues and Profits in 2011 with Increased Global Adoption of its Innovative eC
PHT captures 45% ePRO market share, celebrates 500 trials, expands PHT System to support late phase trials, breaks new ground in proving scientific and economic benefits of ePRO for collecting Read more >>
2011 Achievements and 2012 Prospects BioAlliance Pharma Confirms the Dynamics of Its Core Business
PARIS--(BUSINESS WIRE)-- Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), a company dedicated to specialty and orphan oncology products, today announces its 2011 Read more >>
BioReference to Launch Groundbreaking Solid Tumor Genotyping Test through its GenPath Oncology Laboratory
Test is Most Comprehensive Effort to Match Patient Tumor Profiles to Personalized Cancer Treatment Offered To Date ELMWOOD PARK, N.J.--(BUSINESS WIRE)-- BioReference Laboratories, Inc. (NASDAQ: BRLI) Read more >>
Excel Life Sciences Joins DATATRAK's Connect Partner Program
ELS to Expand the Use of the DATATRAK ONE™ Suite of Products throughout IndiaCLEVELAND, Jan. 25, 2012 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company Read more >>
BioAlliance Pharma Announces Two Key Steps with Its AMEP™ Biotherapy for Metastatic Melanoma
PARIS--(BUSINESS WIRE)-- Regulatory News: BioAlliance Pharma SA (Paris:BIO)(Euronext Paris - BIO), a company dedicated to specialty and orphan oncology products, today announces two key steps in the Read more >>
